Bladder Cancer

1. A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Pre surgical Bladder Cancer Patients

2. Soy Phytochemicals Prevent Orthotopic Growth and Metastasis of Bladder Cancer in Mice by Alterations of Cancer Cell Proliferation and Apoptosis and Tumor Angiogenesis

3. Dietary Soy and Increased Risk of Bladder Cancer: the Singapore Chinese Health Study

Breast Cancer

1. Dietary Isoflavones and Breast Cancer Risk

2. Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives

3. Possibility of Breast Cancer Prevention: Use of Soy Isoflavones and Fermented Soy Beverage Produced Using Probiotics

4. Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review

5. Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms

6. Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy

Colorectal Cancer

1. Soy isoflavone consumption and colorectal cancer risk: a systematic review and meta-analysis

2. Isoflavone and Soy food Intake and Colorectal Cancer Risk: A Case-Control Study in Korea

3. Soy Consumption and Colorectal Cancer Risk in Humans: A Meta-Analysis

Liver Cancer

1. Effect of Genistein on Apoptosis and Proliferation of Hepatocellular Carcinoma Hepa1‑6 Cell Line

2. Isoflavones-Enriched Soy Protein Prevents CCL4-InducedHepatotoxicity in Rats

3. Inhibitory Effect of Genistein on PLC/PRF5 Hepatocellular Carcinoma Cell Line

4. Plasma Isoflavones and Risk of Primary Liver Cancer in Japanese Women and Men with Hepatitis Virus Infection: A Nested Case–Control Study

5. Effect of Genistein and 17‑β Estradiol on the Viability and Apoptosis of Human Hepatocellular Carcinoma HepG2 cell line/a>

6. Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women

Lung Cancer

1. Radioprotection of Lung Tissue by Soy Isoflavones

2. Soy Food Intake and Risk of Lung Cancer: Evidence From the Shanghai Women’s Health Study and a Meta-Analysis

3. Soy Isoflavones Radiosensitize Lung Cancer While Mitigating Normal Tissue Injury

4. Plasma Isoflavones and the Risk of Lung Cancer in Women: A Nested Case–Control Study in Japan

5. Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies

Lymphoma

1. Anti-proliferative Effect of Isoflavones Isolated from Soybean and Soymilk Powder on Lymphoma(DG 75) and Leukemia (CEM) Cell Lines

2. Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case–control study in Japan

3. Soy-Derived Isoflavones Inhibit the Growth of Canine Lymphoid Cell Lines

Prostate Cancer

1. Isoflavones and Prostate Cancer: A Review of Some Critical Issues

2. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy

Stomach Cancer

1. The association between dietary isoflavones intake and gastric cancer risk: a meta-analysis of epidemiological studies

2. Dietary isoflavones and gastric cancer: A brief review of current studies

3. Soy isoflavone intake and stomach cancer risk in Japan: From the Takayama study

4. Isoflavone intake and risk of gastric cancer: a population-based prospective cohort study in Japan

5. Isoflavones from Phytoestrogens and Gastric Cancer Risk: A Nested Case-Control Study within the Korean Multicenter Cancer Cohort/a>